<p>The present invention provides biomarkers useful in the determination of a cell's sensitivity to an ErbB2 blocking compound, methods of use of the biomarkers and kits comprising tools for detecting the biomarkers. The biomarkers comprise components of the ErbB3/PI3K/Akt and their phophorylated forms.</p>
